Business Wire

INNIO to Power UK Grid Stability with Landmark Project Near London

12.11.2025 09:00:00 CET | Business Wire | Press Release

Share

INNIO Group and Clarke Energy are helping to deliver one of the world’s largest high-speed gas engine peaking power plants in Thurrock, England. The two companies already signed a contract to this effect in 2024. The 450-MW flexible generation facility is being constructed by Statera Energy, a leading developer, owner, and operator of flexible energy assets. With full operations targeted for late 2026, it is expected to provide enough power for up to 1 million homes in Southeast England—helping to support the UK’s energy resilience strategy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112767813/en/

Thurrock Flexible Generation Project (c) Statera Energy

As the UK transitions to renewables, grid stability is more critical than ever. The Thurrock Flexible Generation Project is designed to respond rapidly to fluctuations in supply and demand, ensuring reliable electricity during peak periods and when renewable output varies. Located near London, the plant plays an important role in balancing the capital’s energy needs, supporting the UK’s secure, low-carbon future.

“This project sets a new benchmark for grid flexibility in the UK. With scalable, reliable, and future-ready energy, we’re helping accelerate the UK’s shift toward a more resilient power infrastructure,” said Dr. Olaf Berlien, President & CEO of INNIO Group.

Matt Arnold, Director of BESS & Flex-Gen at Statera Energy, stated: “Thurrock Power is a key milestone in Statera’s mission to deliver cost-effective flexibility at scale. As the UK’s largest flexible generation site, it will help balance the grid and support renewables. Clarke Energy and INNIO’s Jenbacher technology offer speed, fuel flexibility, and reliability – key for energy security in a decarbonizing system.”

INNIO’s energy solution combines high electrical efficiency, rapid start-up in less than 5 minutes, and cost advantages over alternative technologies. Its scalable deployment allows for high efficiency at partial loads. This flexibility enables the plant to swiftly respond to fluctuations in electricity supply and demand. The Jenbacher “Ready for H2” engines in Thurrock will operate primarily on natural gas but are designed to run on a variety of fuel blends, including biomethane and hydrogen.

About INNIO Group

INNIO Group is a leading energy solution and service provider that empowers industries and communities to make sustainable energy work today. With its Jenbacher and Waukesha product brands and its AI-powered myplant digital platform, INNIO Group offers innovative solutions for data center power infrastructure, distributed power generation, and compression applications. With its flexible, scalable, and resilient energy solutions and services, INNIO Group enables its customers to drive the energy transition across the energy value chain and ensures reliable energy supply even where the grid is not available.

For more information, visit INNIO Group’s website at innio.com. Follow INNIO Group on X and LinkedIn.

INNIO, Jenbacher, Waukesha, and myplant are trademarks or registered trademarks of the INNIO Group, or one of its subsidiaries, in the European Union, the United States and in other countries. For a list of INNIO Group trademarks, please visit innio.com/trademarks. All other trademarks and company names are the property of their respective owners.

About Statera Energy

Statera Energy is a UK-based energy company that develops, owns, and operates flexible generation, battery storage, pumped hydro and green hydrogen projects. These assets will help the UK build more renewable energy, more quickly, by providing the flexible capacity needed to balance the future grid whilst lowering carbon emissions and delivering best value for energy users. Statera has over 2.1GW of assets delivered or under construction, and plans to deliver 8GW of flexibility assets by 2030 and has a total pipeline of over 16GW. For more information visit www.stateraenergy.co.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251112767813/en/

Contacts

For further information please contact:

Susanne Reichelt
INNIO Group
+43 664 80833 2382
susanne.reichelt@innio.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye